← Open Payments lookup

JEMIN GAJIPARA: Open Payments

NPI 1922205939 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,232 in 53 payments from 15 companies in 2025. Trend: 2023 $3,347 · 2024 $2,161 · 2025 $1,232

Food & beverage: $1,153Travel & lodging: $79
CompanyPaymentsAmount
TerSera Therapeutics LLC10$213
Collegium Pharmaceutical, Inc.13$199
Curonix LLC4$154
PROTEGA PHARMACEUTIALS INC6$138
BIOTRONIK NRO, Inc.1$104
VERTEX PHARMACEUTICALS INCORPORATED4$90
Valinor Pharma, LLC4$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$59
Boston Scientific Corporation2$41
Medtronic, Inc.2$40

Products named: Prialt, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, ROXYBOND, XTAMPZA, Prospera, JOURNAVX, Nucynta, MOVANTIK.

Industry payments across TX — which companies pay providers there.